InMed Pharmaceuticals (INM) Inventory (2021 - 2025)

InMed Pharmaceuticals has reported Inventory for 5 years, with the latest figure at $947898.0 in Q4 2025.

• On a quarterly basis, Inventory fell 14.09% year-over-year to $947898.0 in Q4 2025; TTM through Dec 2025 was $947898.0, a 14.09% decrease from a year earlier, with the FY2025 full-year figure at $961173.0, down 22.76% from the prior year.
• Inventory was $947898.0 for Q4 2025 at InMed Pharmaceuticals, up from $890807.0 in the prior quarter.
• The five-year high for Inventory was $2.5 million in Q2 2022, with the low at $744839.0 in Q4 2023.
• Average Inventory over 5 years is $1.3 million, with a median of $1.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory jumped 63.17% in 2022, then plunged 53.84% in 2023.
• Over 5 years, Inventory stood at $988822.0 in 2021, then surged by 63.17% to $1.6 million in 2022, then slumped by 53.84% to $744839.0 in 2023, then soared by 48.13% to $1.1 million in 2024, then dropped by 14.09% to $947898.0 in 2025.
• The last three Inventory figures came in at $947898.0 (Q4 2025), $890807.0 (Q3 2025), and $961173.0 (Q2 2025), per Business Quant data.